<?xml version="1.0" encoding="UTF-8"?>
<html><body class="spl" id="spl">
<div class="DocumentTitle"><p class="DocumentTitle"><strong>ERGOCALCIFEROL - ergocalciferol capsule </strong><br>Physicians Total Care, Inc.<br></p></div>
<h1></h1>
<div class="Contents">
<div class="Section" data-sectionCode="48780-1">
<a name="section-1"></a><p></p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="section-1"></a><p></p>
<p class="First"><span class="Bold">Rx Only</span></p>
</div>
<div class="Section" data-sectionCode="34089-3">
<a name="section-2"></a><p></p>
<h1>DESCRIPTION</h1>
<p class="First">Ergocalciferol Capsules, USP is a synthetic calcium regulator for 
oral administration.</p>
<p>Ergocalciferol is a white, colorless crystal, insoluble in water, soluble in 
organic solvents, and slightly soluble in vegetable oils. It is affected by air 
and by light. Ergosterol or provitamin D<span class="Sub">2</span> is found in 
plants and yeast and has no antirachitic activity.</p>
<p>There are more than 10 substances belonging to a group of steroid compounds, 
classified as having vitamin D or antirachitic activity.</p>
<p>One USP Unit of vitamin D<span class="Sub">2</span> is equivalent to one 
International Unit (IU), and 1 mcg of vitamin D<span class="Sub">2</span> is equal 
to 40 IU.</p>
<p>Each softgel capsule, for oral administration, contains Ergocalciferol, USP 
1.25 mg (equivalent to 50,000 USP units of Vitamin D), in an edible vegetable 
oil.</p>
<p>Ergocalciferol, also called vitamin D<span class="Sub">2</span> ,is 9, 
10-secoergosta-5, 7,10(19),22-tetraen-3-ol,(3β,5<span class="Italics">Z</span>,7<span class="Italics">E</span>,22<span class="Italics">E</span>)-; (C<span class="Sub">28</span>H<span class="Sub">44</span>O) with a molecular weight of 396.65, and has the following 
structural formula: <br></p>
<p><img alt="image of chemical structure" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=88218156-081a-4809-8143-f97bdab194ba&amp;name=chemical%20structure.jpg"></p>
<p><span class="Bold">Inactive Ingredients:</span> D&amp;C Yellow #10, FD&amp;C Blue 
#1, Gelatin, Glycerin, Purified Water, Refined Soybean Oil.</p>
</div>
<div class="Section" data-sectionCode="34090-1">
<a name="section-3"></a><p></p>
<h1>CLINICAL PHARMACOLOGY</h1>
<p class="First">The <span class="Italics">in vivo</span> synthesis of the major 
biologically active metabolites of vitamin D occurs in two steps. The first 
hydroxylation of ergocalciferol takes place in the liver (to 25-hydroxyvitamin 
D) and the second in the kidneys (to 1,25-dihydroxy- vitamin D). Vitamin D 
metabolites promote the active absorption of calcium and phosphorus by the small 
intestine, thus elevating serum calcium and phosphate levels sufficiently to 
permit bone mineralization. Vitamin D metabolites also mobilize calcium and 
phosphate from bone and probably increase the reabsorption of calcium and 
perhaps also of phosphate by the renal tubules.</p>
<p>There is a time lag of 10 to 24 hours between the administration of vitamin D 
and the initiation of its action in the body due to the necessity of synthesis 
of the active metabolites in the liver and kidneys. Parathyroid hormone is 
responsible for the regulation of this metabolism in the kidneys.</p>
</div>
<div class="Section" data-sectionCode="34067-9">
<a name="section-4"></a><p></p>
<h1>INDICATIONS AND USAGE</h1>
<p class="First">Ergocalciferol Capsules, USP are indicated for use in the treatment of 
<span class="product-label-link" type="condition" conceptid="140362" conceptname="Hypoparathyroidism">hypoparathyroidism</span>, refractory <span class="product-label-link" type="condition" conceptid="4189941" conceptname="Rickets">rickets</span>, also known as vitamin D resistant 
<span class="product-label-link" type="condition" conceptid="4189941" conceptname="Rickets">rickets</span>, and familial <span class="product-label-link" type="condition" conceptid="4177973" conceptname="Hypophosphatemia">hypophosphatemia</span>.</p>
</div>
<div class="Section" data-sectionCode="34070-3">
<a name="section-5"></a><p></p>
<h1>CONTRAINDICATIONS</h1>
<p class="First">Ergocalciferol Capsules, USP are contraindicated in patients with <span class="product-label-link" type="condition" conceptid="435511" conceptname="Hypercalcemia">hypercalcemia</span>, 
<span class="product-label-link" type="condition" conceptid="194993" conceptname="Intestinal malabsorption">malabsorption syndrome</span>, abnormal sensitivity to the toxic effects of vitamin D, 
and <span class="product-label-link" type="condition" conceptid="435522" conceptname="Hypervitaminosis D">hypervitaminosis D</span>.</p>
</div>
<div class="Section" data-sectionCode="34071-1">
<a name="section-6"></a><p></p>
<h1>WARNINGS</h1>
<p class="First"><span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">Hypersensitivity</span> to vitamin D may be one etiologic factor in 
infants with idiopathic <span class="product-label-link" type="condition" conceptid="435511" conceptname="Hypercalcemia">hypercalcemia</span>. In these cases vitamin D must be strictly 
restricted.</p>
<p>Keep out of the reach of children.</p>
</div>
<div class="Section" data-sectionCode="42232-9">
<a name="section-7"></a><p></p>
<h1>PRECAUTIONS</h1>
<a href="http://"></a>General<p class="First">Vitamin D administration from fortified foods, dietary 
supplements, self-administered and prescription drug sources should be 
evaluated. Therapeutic dosage should be readjusted as soon as there is clinical 
improvement. Dosage levels must be individualized and great care exercised to 
prevent serious toxic effects. IN VITAMIN D RESISTANT <span class="product-label-link" type="condition" conceptid="4189941" conceptname="Rickets">RICKETS</span> THE RANGE BETWEEN 
THERAPEUTIC AND TOXIC DOSES IS NARROW. When high therapeutic doses are used 
progress should be followed with frequent blood calcium determinations.</p>
<p>In the treatment of <span class="product-label-link" type="condition" conceptid="140362" conceptname="Hypoparathyroidism">hypoparathyroidism</span>, intravenous calcium, parathyroid 
hormone, and/or dihydrotachysterol may be required.</p>
<p>Maintenance of a normal serum phosphorous level by dietary phosphate 
restriction and/or administration of aluminum gels as intestinal phosphate 
binders in those patients with <span class="product-label-link" type="condition" conceptid="4065502" conceptname="Hyperphosphatemia">hyperphosphatemia</span> as frequently seen in renal 
<span class="product-label-link" type="condition" conceptid="75924" conceptname="Osteodystrophy">osteodystrophy</span> is essential to prevent metastatic calcification.</p>
<p>Adequate dietary calcium is necessary for clinical response to vitamin D 
therapy.</p>
<p>Protect from light.</p>
<a href="http://"></a><a href="http://"></a>Drug Interactions<p>Mineral oil interferes with the absorption of fat-soluble 
vitamins, including vitamin D preparations. Administration of thiazide diuretics 
to hypoparathyroid patients who are concurrently being treated with 
ergocalciferol may cause <span class="product-label-link" type="condition" conceptid="435511" conceptname="Hypercalcemia">hypercalcemia</span>.</p>
<a href="http://"></a><a href="http://"></a>Carcinogenesis, Mutagenesis, Impairment of 
Fertility<p>No long-term animal studies have been performed to evaluate the 
drug's potential in these areas.</p>
<a href="http://"></a><a href="http://"></a>Pregnancy Category C<p>Animal reproduction studies have shown fetal abnormalities in 
several species associated with <span class="product-label-link" type="condition" conceptid="435522" conceptname="Hypervitaminosis D">hypervitaminosis D</span>. These are similar to the 
<span class="product-label-link" type="condition" conceptid="4147787" conceptname="Supravalvar aortic stenosis">supravalvular aortic stenosis</span> syndrome described in infants by Black in England 
(1963). This syndrome was characterized by <span class="product-label-link" type="condition" conceptid="4147787" conceptname="Supravalvar aortic stenosis">supravalvular aortic stenosis</span>, elfin 
facies, and <span class="product-label-link" type="condition" conceptid="440389" conceptname="Mental retardation">mental retardation</span>. For the protection of the fetus, therefore, the 
use of vitamin D in excess of the recommended dietary allowance during normal 
pregnancy should be avoided unless, in the judgment of the physician, potential 
benefits in a specific, unique case outweigh the significant hazards involved. 
The safety in excess of 400 USP units of vitamin D daily during pregnancy has 
not been established.</p>
<a href="http://"></a><a href="http://"></a>Nursing Mothers<p>Caution should be exercised when ergocalciferol is administered 
to a nursing woman. In a mother given large doses of vitamin D, 
25-hydroxycholecalciferol appeared in the milk and caused <span class="product-label-link" type="condition" conceptid="435511" conceptname="Hypercalcemia">hypercalcemia</span> in her 
child. Monitoring of the infant's serum calcium concentration is required in 
that case (Goldberg, 1972).</p>
<a href="http://"></a><a href="http://"></a>Pediatric Use<p>Pediatric doses must be individualized (see <span class="Bold"><a href="#dosage">DOSAGE AND ADMINISTRATION</a></span>).</p>
<a href="http://"></a><a href="http://"></a>Geriatric Use<p>Clinical studies of ergocalciferol did not include sufficient 
numbers of subjects aged 65 and over to determine whether they respond 
differently from younger subjects. Other reported clinical experience has not 
identified differences in responses between the elderly and younger patients. A 
few published reports have suggested that the absorption of orally administered 
vitamin D may be attenuated in elderly compared to younger individuals. In 
general, dose selection for an elderly patient should be cautious, usually 
starting at the low end of the dosing range, reflecting the greater frequency of 
decreased hepatic, renal, or cardiac function, and of concomitant disease or 
other drug therapy.</p>
</div>
<div class="Section" data-sectionCode="34084-4">
<a name="section-8"></a><p></p>
<h1>ADVERSE REACTIONS</h1>
<p class="First"><span class="product-label-link" type="condition" conceptid="435522" conceptname="Hypervitaminosis D">Hypervitaminosis D</span> is characterized by effects on the following 
organ system:</p>
<p><span class="Bold">Renal:</span> Impairment of renal function with <span class="product-label-link" type="condition" conceptid="79936" conceptname="Polyuria">polyuria</span>, 
<span class="product-label-link" type="condition" conceptid="40304526" conceptname="Nocturia">nocturia</span>, <span class="product-label-link" type="condition" conceptid="432454" conceptname="Excessive thirst">polydipsia</span>, <span class="product-label-link" type="condition" conceptid="4215809" conceptname="Hypercalciuria">hypercalciuria</span>, reversible <span class="product-label-link" type="condition" conceptid="4261202" conceptname="Uremia">azotemia</span>, <span class="product-label-link" type="condition" conceptid="316866" conceptname="Hypertensive disorder">hypertension</span>, 
<span class="product-label-link" type="condition" conceptid="4171974" conceptname="Nephrocalcinosis">nephrocalcinosis</span>, generalized <span class="product-label-link" type="condition" conceptid="4030365" conceptname="Vascular calcification">vascular calcification</span>, or irreversible renal 
insufficiency which may result in <span class="product-label-link" type="condition" conceptid="4306655" conceptname="Death">death</span>.</p>
<p><span class="Bold">CNS:</span> <span class="product-label-link" type="condition" conceptid="440389" conceptname="Mental retardation">Mental retardation</span>.</p>
<p><span class="Bold">Soft Tissues:</span> Widespread calcification of the soft 
tissues, including the heart, blood vessels, renal tubules, and lungs.</p>
<p><span class="Bold">Skeletal:</span> Bone demineralization (<span class="product-label-link" type="condition" conceptid="80502" conceptname="Osteoporosis">osteoporosis</span>) in 
adults occurs concomitantly.<br>Decline in the average rate of linear growth and 
increased mineralization of bones in infants and children (<span class="product-label-link" type="condition" conceptid="25780" conceptname="Pituitary dwarfism">dwarfism</span>), vague 
<span class="product-label-link" type="condition" conceptid="4329041" conceptname="Pain">aches</span>, <span class="product-label-link" type="condition" conceptid="4060220" conceptname="Stiff neck">stiffness</span>, and <span class="product-label-link" type="condition" conceptid="437113" conceptname="Asthenia">weakness</span>.</p>
<p><span class="Bold">Gastrointestinal:</span> <span class="product-label-link" type="condition" conceptid="31967" conceptname="Nausea">Nausea</span>, <span class="product-label-link" type="condition" conceptid="442165" conceptname="Loss of appetite">anorexia</span>, <span class="product-label-link" type="condition" conceptid="75860" conceptname="Constipation">constipation</span>. 
</p>
<p><span class="Bold">Metabolic:</span> Mild <span class="product-label-link" type="condition" conceptid="435517" conceptname="Acidosis">acidosis</span>, <span class="product-label-link" type="condition" conceptid="439777" conceptname="Anemia">anemia</span>, <span class="product-label-link" type="condition" conceptid="4134010" conceptname="Weight decreased">weight loss</span>.G</p>
</div>
<div class="Section" data-sectionCode="34088-5">
<a name="section-9"></a><p></p>
<h1>OVERDOSAGE</h1>
<p class="First"><span class="Bold">The effects of administered vitamin D can 
persist for two or more months after cessation of treatment.</span></p>
<p><span class="product-label-link" type="condition" conceptid="435522" conceptname="Hypervitaminosis D">Hypervitaminosis D</span> is characterized by:</p>
<ol>
<li><span class="product-label-link" type="condition" conceptid="435511" conceptname="Hypercalcemia">Hypercalcemia</span> with <span class="product-label-link" type="condition" conceptid="442165" conceptname="Loss of appetite">anorexia</span>, <span class="product-label-link" type="condition" conceptid="31967" conceptname="Nausea">nausea</span>, <span class="product-label-link" type="condition" conceptid="437113" conceptname="Asthenia">weakness</span>, <span class="product-label-link" type="condition" conceptid="4134010" conceptname="Weight decreased">weight loss</span>, vague <span class="product-label-link" type="condition" conceptid="4329041" conceptname="Pain">aches</span> and 
<span class="product-label-link" type="condition" conceptid="4060220" conceptname="Stiff neck">stiffness</span>, <span class="product-label-link" type="condition" conceptid="75860" conceptname="Constipation">constipation</span>, <span class="product-label-link" type="condition" conceptid="440389" conceptname="Mental retardation">mental retardation</span>, <span class="product-label-link" type="condition" conceptid="439777" conceptname="Anemia">anemia</span>, and mild <span class="product-label-link" type="condition" conceptid="435517" conceptname="Acidosis">acidosis</span>.</li>
<li>Impairment of renal function with <span class="product-label-link" type="condition" conceptid="79936" conceptname="Polyuria">polyuria</span>, <span class="product-label-link" type="condition" conceptid="40304526" conceptname="Nocturia">nocturia</span>, <span class="product-label-link" type="condition" conceptid="432454" conceptname="Excessive thirst">polydipsia</span>, 
<span class="product-label-link" type="condition" conceptid="4215809" conceptname="Hypercalciuria">hypercalciuria</span>, reversible <span class="product-label-link" type="condition" conceptid="4261202" conceptname="Uremia">azotemia</span>, <span class="product-label-link" type="condition" conceptid="316866" conceptname="Hypertensive disorder">hypertension</span>, <span class="product-label-link" type="condition" conceptid="4171974" conceptname="Nephrocalcinosis">nephrocalcinosis</span>, generalized 
<span class="product-label-link" type="condition" conceptid="4030365" conceptname="Vascular calcification">vascular calcification</span>, or irreversible <span class="product-label-link" type="condition" conceptid="192359" conceptname="Renal failure syndrome">renal insufficiency</span> which may result in 
<span class="product-label-link" type="condition" conceptid="4306655" conceptname="Death">death</span>. </li>
<li>Widespread calcification of the soft tissues, including the heart, blood 
vessels, renal tubules, and lungs. Bone demineralization (<span class="product-label-link" type="condition" conceptid="80502" conceptname="Osteoporosis">osteoporosis</span>) in 
adults occurs concomitantly.</li>
<li>Decline in the average rate of linear growth and increased mineralization of 
bones in infants and children (<span class="product-label-link" type="condition" conceptid="25780" conceptname="Pituitary dwarfism">dwarfism</span>).</li>
</ol>
<p>The treatment of <span class="product-label-link" type="condition" conceptid="435522" conceptname="Hypervitaminosis D">hypervitaminosis D</span> with <span class="product-label-link" type="condition" conceptid="435511" conceptname="Hypercalcemia">hypercalcemia</span> consists of immediate 
withdrawal of the vitamin, a low calcium diet, generous intake of fluids, along 
with symptomatic and supportive treatment. Hypercalcemic crisis with 
<span class="product-label-link" type="condition" conceptid="435796" conceptname="Dehydration">dehydration</span>, <span class="product-label-link" type="condition" conceptid="4229897" conceptname="Stupor">stupor</span>, <span class="product-label-link" type="condition" conceptid="380834" conceptname="Coma">coma</span>, and <span class="product-label-link" type="condition" conceptid="4261202" conceptname="Uremia">azotemia</span> requires more vigorous treatment. The 
first step should be hydration of the patient. Intravenous saline may quickly 
and significantly increase urinary calcium excretion. A loop diuretic 
(furosemide or ethacrynic acid) may be given with the saline infusion to further 
increase renal calcium excretion. Other reported therapeutic measures include 
dialysis or the administration of citrates, sulfates, phosphates, 
corticosteroids, EDTA (ethylenediaminetetraacetic acid), and mithramycin via 
appropriate regimens. With appropriate therapy, recovery is the usual outcome 
when no permanent damage has occurred. <span class="product-label-link" type="condition" conceptid="4306655" conceptname="Death">Deaths</span> via renal or cardiovascular 
failure have been reported.</p>
<p>The LD<span class="Sub">50</span> in animals is unknown. The toxic oral dose of 
ergocalciferol in the dog is 4 mg/kg.</p>
</div>
<div class="Section" data-sectionCode="34068-7">
<a name="section-10"></a><p></p>
<h1>DOSAGE AND ADMINISTRATION</h1>
<p class="First">THE RANGE BETWEEN THERAPEUTIC AND TOXIC DOSES IS NARROW.</p>
<p><span class="Bold">Vitamin D Resistant <span class="product-label-link" type="condition" conceptid="4189941" conceptname="Rickets">Rickets</span>:</span> 12,000 to 500,000 USP 
units daily.</p>
<p><span class="Bold"><span class="product-label-link" type="condition" conceptid="140362" conceptname="Hypoparathyroidism">Hypoparathyroidism</span>:</span> 50,000 to 200,000 USP units daily 
concomitantly with calcium lactate 4 g, six times per day.</p>
<p>DOSAGE MUST BE INDIVIDUALIZED UNDER CLOSE MEDICAL SUPERVISION.</p>
<p>Calcium intake should be adequate. Blood calcium and phosphorus 
determinations must be made every 2 weeks or more frequently if necessary. 
X-rays of the bones should be taken every month until condition is corrected and 
stabilized.</p>
</div>
<div class="Section" data-sectionCode="34069-5">
<a name="section-11"></a><p></p>
<h1>HOW SUPPLIED</h1>
<p class="First">Each green, oval softgel capsule is imprinted with A3 and 
contains 1.25 mg (50,000 USP units vitamin D) of ergocalciferol, USP.</p>
<a name="i7604574b-5efb-4d85-8992-735b662a9b9b"></a><table width="30%"><tbody class="Headless">
<tr class="First">
<td>Bottles of 2<br>
</td>
<td>NDC 54868-5799-4<br>
</td>
</tr>
<tr>
<td>Bottles of 4<br>Bottles of 8<br>
</td>
<td>NDC 54868-5799-1<br>NDC 54868-5799-5<br>
</td>
</tr>
<tr>
<td>Bottles of 10<br>
</td>
<td>NDC 54868-5799-0<br>
</td>
</tr>
<tr>
<td>Bottles of 12<br>
</td>
<td>NDC 54868-5799-2<br>
</td>
</tr>
<tr class="Last">
<td>Bottles of 20<br>
</td>
<td>NDC 54868-5799-3<br>
</td>
</tr>
</tbody></table>
<p><br></p>
<a href="#section-"></a><a href="#section-"></a><p>Store at 20°– 25°C (68°–77°F) [See USP Controlled Room 
Temperature].</p>
<p>Protect from light and moisture.</p>
<p>Dispense in a tight, light-resistant container as defined in the USP.</p>
<a href="#section-"></a><a href="#section-"></a><p><br></p>
<p>Manufactured by: Swiss Caps AG<br>Kirchberg, 
Switzerland<br>Distributed by: Breckenridge Pharmaceutical, Inc.<br>Boca Raton, 
FL 33487</p>
<p>Rev. 04/09</p>
<br><p><span class="Bold">Relabeling and Repackaging by:</span><br>Physicians Total Care, Inc.<br>Tulsa, OK       74146<br></p>
</div>
<div class="Section" data-sectionCode="51945-4">
<a name="section-12"></a><p></p>
<h1>PRINCIPAL DISPLAY PANEL - 1.25 mg Bottle Label</h1>
<p class="First"><span class="Bold">Vitamin D</span><br>(Ergocalciferol<br>Capsules, USP)</p>
<p><span class="Bold">1.25 mg*</span></p>
<p><span class="Bold">(50,000 USP Units)</span></p>
<p><span class="Bold">Rx Only</span></p>
<p><img alt="image of package label" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=88218156-081a-4809-8143-f97bdab194ba&amp;name=package%20label.jpg"></p>
</div>
</div>
<div class="DataElementsTables">
<table class="contentTablePetite" cellSpacing="0" cellPadding="3" width="100%"><tbody>
<tr><td class="contentTableTitle">
<strong>ERGOCALCIFEROL 		
					</strong><br><span class="contentTableReg">ergocalciferol capsule</span>
</td></tr>
<tr><td><table width="100%" cellpadding="5" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Information</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Product Type</td>
<td class="formItem">HUMAN PRESCRIPTION DRUG LABEL</td>
<td class="formLabel">Item Code (Source)</td>
<td class="formItem">NDC:54868-5799(NDC:51991-604-01)</td>
</tr>
<tr class="formTableRow">
<td width="30%" class="formLabel">Route of Administration</td>
<td class="formItem">ORAL</td>
<td width="30%" class="formLabel">DEA Schedule</td>
<td class="formItem">    
							</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="3" class="formHeadingTitle">Active Ingredient/Active Moiety</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Basis of Strength</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">
<strong>ERGOCALCIFEROL</strong> (ERGOCALCIFEROL) </td>
<td class="formItem">ERGOCALCIFEROL</td>
<td class="formItem">1.25 mg</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="2" class="formHeadingTitle">Inactive Ingredients</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>D&amp;C YELLOW NO. 10</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>FD&amp;C BLUE NO. 1</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>GELATIN</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>GLYCERIN</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>WATER</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>SOYBEAN OIL</strong></td>
<td class="formItem"> </td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Characteristics</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Color</td>
<td class="formItem">green</td>
<td class="formLabel">Score</td>
<td class="formItem">no score</td>
</tr>
<tr class="formTableRow">
<td class="formLabel">Shape</td>
<td class="formItem">OVAL</td>
<td class="formLabel">Size</td>
<td class="formItem">13mm</td>
</tr>
<tr class="formTableRowAlt">
<td class="formLabel">Flavor</td>
<td class="formItem"></td>
<td class="formLabel">Imprint Code</td>
<td class="formItem">A3</td>
</tr>
<tr class="formTableRow">
<td class="formLabel">Contains</td>
<td class="formItem">    </td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="5" class="formHeadingTitle">Packaging</td></tr>
<tr>
<th scope="col" width="1" class="formTitle">#</th>
<th scope="col" class="formTitle">Item Code</th>
<th scope="col" class="formTitle">Package Description</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem">NDC:54868-5799-0</td>
<td class="formItem">10  in 1 BOTTLE, PLASTIC</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
<tr class="formTableRow">
<th scope="row" class="formItem">2</th>
<td class="formItem">NDC:54868-5799-1</td>
<td class="formItem">4  in 1 BOTTLE, PLASTIC</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">3</th>
<td class="formItem">NDC:54868-5799-2</td>
<td class="formItem">12  in 1 BOTTLE, PLASTIC</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
<tr class="formTableRow">
<th scope="row" class="formItem">4</th>
<td class="formItem">NDC:54868-5799-3</td>
<td class="formItem">20  in 1 BOTTLE, PLASTIC</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">5</th>
<td class="formItem">NDC:54868-5799-4</td>
<td class="formItem">2  in 1 BOTTLE, PLASTIC</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
<tr class="formTableRow">
<th scope="row" class="formItem">6</th>
<td class="formItem">NDC:54868-5799-5</td>
<td class="formItem">8  in 1 BOTTLE, PLASTIC</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td class="normalizer"><table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Marketing Information</span></td></tr>
<tr>
<th scope="col" class="formTitle">Marketing Category</th>
<th scope="col" class="formTitle">Application Number or Monograph Citation</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">ANDA</td>
<td class="formItem">ANDA040833</td>
<td class="formItem">07/12/2007</td>
<td class="formItem"></td>
</tr>
</table></td></tr>
</tbody></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite"><tr><td colspan="4" class="formHeadingReg">
<span class="formHeadingTitle">Labeler - </span>Physicians Total Care, Inc.
							(194123980)
						</td></tr></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Establishment</span></td></tr>
<tr>
<th scope="col" class="formTitle">Name</th>
<th scope="col" class="formTitle">Address</th>
<th scope="col" class="formTitle">ID/FEI</th>
<th scope="col" class="formTitle">Business Operations</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">Physicians Total Care, Inc.</td>
<td class="formItem"></td>
<td class="formItem">194123980</td>
<td class="formItem">relabel, repack</td>
</tr>
</table>
</div>
<p><div class="EffectiveDate">Revised: 10/2010<div class="DocumentMetadata">
<div>
<a href="javascript:toggleMixin();">Document Id: </a>91d78653-caeb-4360-a9b0-d31b4aec2f93</div>
<div>Set id: 88218156-081a-4809-8143-f97bdab194ba</div>
<div>Version: 2</div>
<div>Effective Time: 20101011</div>
</div>
</div> <div class="DistributorName">Physicians Total Care, Inc.</div></p>
</body></html>
